Ting-Fang Chou Selected Research

N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amine

1/2022

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ting-Fang Chou Research Topics

Disease

2	Infections 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 12/2021
2	Neoplasms (Cancer) 01/2020 - 01/2011
1	Colitis 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016
1	Hypersensitivity (Allergy) 02/2015
1	Peritonitis 01/2011

Drug/Important Bio-Agent (IBA)

2	Death-Associated Protein KinasesIBA 01/2020 - 01/2011
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 01/2022
1	CollagenIBA 01/2022
1	CytokinesIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	LigandsIBA 12/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Uric Acid (Urate)IBA 01/2011

Therapy/Procedure

1	Transplantation 02/2015